Inhibikase Therapeutics Inc S-1

Inhibikase Therapeutics Inc, which is in the Biological Products (No Diagnostic Substances) [2836] industry, SEC S-1 filing on June 11, 2021 had 82223 (cleaned) words - 600 were utilized for the visualizations.

Top Words:

1. may - 991 instances
2. product - 746 instances
3. stock - 701 instances
4. company - 639 instances
5. clinical - 604 instances

See the parsed data used in the visualization here.
View the actual filing on the SEC website here